MGC Pharmaceuticals

Australian Cannabis Index | New York and New Jersey Face Potential Pot Shortage

Cannabis producers are now well-positioned to capitalize on this supply shortfall, which is only expected to worsen once the Big Apple's nascent recreational market begins to build...

Australian Cannabis Index | Credit Suisse Group Ceases Pot Stock Transactions

The fallout of this decision can already be seen in the performance of the AdvisorShares Pure US Cannabis ETF, which has seen its share price dive by more than 20% since February 2...

Australian Cannabis Index | Philip Morris Weighs Up Cannabis Play

The tobacco juggernaut previously dipped its toes into the cannabis sector roughly five years ago, when it invested in Israeli medical cannabis company Syqe Medical.The outlook of ...

MGC Pharma Becomes Pot Stock On The LSE

MCG Pharma makes history as the first medicinal cannabis firm to be admitted to the London Stock Exchange.MGC Pharmaceuticals Ltd (ASX: MXC), a European based and Australian listed...

HMMJ Pushes Past Australian Cannabis Index After Georgia Election Victory

Industry experts believe that a Democrat-controlled Senate may be more amenable to cannabis legalization at the federal level, after years of GOP-driven opposition.The cannabis ind...

MGC Pharma's 'ArtemiC' Results To Come Next Week

MGC Pharmaceuticals expects to see the complete results of its novel anti-inflammatory formula 'ArtemiC' next week. MGC Pharmaceuticals (ASX: MXC), has today provided an update on ...

MGC Pharma Provides Update on Nutraceutical Company Sale

MGC Pharma has updated investors on the progress of its sale of MGC Nutraceuticals to the U.S. based Onassis Holdings Corp. MGC Pharmaceuticals Ltd (ASX: MXC), today provided an up...

Will Betting Big on Coronavirus Lead to a Rebound for the Australian Cannabis Index?

We're taking an in depth look at some of the ASX-listed shares that have driven the market forward over the last week. The Australian cannabis market has continued to expand at ara...

MGC's Cannabinoid Formula Shows Success Treating Brain Tumours

MGC Pharmaceuticals's novel cannabinoid combination of CBD and CBG shows signs of encouraging the cell death of glioblastoma cells. MGC Pharmaceuticals (ASX:MXC) today announced th...

MGC Pharma's Roby Zomer Talks Medical Cannabis

Roby Zomer is the CEO, Managing Director and Co-Founder of MGC Pharmaceuticals (ASX:MXC), an ASX-listed biotech focused on the development of phytocannabinoid medicines. Welcome to...